ConductScience.org, home

Trial · NCT02232425

Outcomes13

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYMean Fold Change in Geometric Mean Intravaginal Ejaculatory Latency Time (IELT)Last 4 weeks of treatment compared to baselineEfficacy data set excluding outliersNo units for fold changeGEOMETRIC_MEAN
SECONDARYProportion of Participants Rating Their PE as Better or Much Better, on the Clinical Global Impression of Change (CGIC) ScaleBaseline to the end of treatment (approximately 8 weeks)Intent to treat, excluding outliersproportion of participantsNUMBER
SECONDARYProportion of Participants With Greater Than or Equal to (≥) 2.5 Fold Increase in Intravaginal Ejaculatory Latency Time (IELT)Last 4 weeks of treatment compared to baselineIntent to treat, excluding outliersProportion of participantsNUMBER
SECONDARYMean Fold Change in Arithmetic IELT (Intravaginal Ejaculatory Latency Time)Last 4 weeks of treatment compared to baselineIntent to treat, excluding outliersNo units for fold changeMEAN
SECONDARYMean Change in Score on Control of Timing of EjaculationLast 4 weeks of treatment compared to baselineIntent to treat, excluding outliersunits on a scaleMEAN
SECONDARYMean Change in Score on Ejaculation-related Personal DistressLast 4 weeks of treatment compared to baselineIntent to treat, excluding outliersunits on a scaleMEAN
SECONDARYProportion of Participants With ≥ 1 Category of Improvement in Satisfaction With Sexual Intercourse, on the Premature Ejaculation Profile (PEP) QuestionnaireBaseline to 8 weeksIntent to treat, excluding outliersadjusted proportion of participantsNUMBER
SECONDARYProportion of Participants With ≥ 1 Category of Improvement in Control Over Ejaculation During Sexual Intercourse on the Premature Ejaculation Profile (PEP) QuestionnaireBaseline to 8 weeksIntent to treat, excluding outliersadjusted proportion of participantsNUMBER
SECONDARYProportion of Participants With ≥ 1 Category of Improvement in Ejaculation-related Distress on the Premature Ejaculation Profile ( PEP) QuestionnaireBaseline to 8 weeksIntent to treat, excluding outliersadjusted proportion of participantsNUMBER
SECONDARYProportion of Participants With ≥ 1 Category of Improvement in Ejaculation-related Interpersonal Difficulty on the Premature Ejaculation Profile (PEP) QuestionnaireBaseline to 8 weeksIntent to treat, excluding outliersadjusted proportion of participantsNUMBER
SECONDARYProportion of Participants With ≥ 2 Category Increase in Control and ≥ 1 Category Decrease in Personal Distress on a Patient Reported Outcome (PRO) MeasureBaseline to 8 weeksIntent to treat, excluding outliersproportion of participantsNUMBER
SECONDARYChange in Percentage of Intercourse Attempts Lasting Longer Than 1 Minute From Baseline to Last 4 Weeks on TreatmentBaseline to last 4 weeks on treatmentIntent to treat, excluding outlierspercentage of attemptsMEAN
SECONDARYIncidence of Treatment-emergent Adverse EventsStart of Treatment to end of study (approximately 10 weeks)Intent to treat, excluding outliersparticipantsNUMBER

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02232425/outcomes